Pleural Effusion Clinical Trial
Official title:
Post-Market Clinical Follow-up Study to Assess the Safety, Performance, and Clinical Benefit of the CE-marked Drainova® ArgentiC Catheter
The goal of this observational study is to learn about the performance of the drainova® ArgentiC Catheter in clinical routine, which is used to treat fluid accumulations in hollow body structures. The device is already on the market and participants receive the catheter as part of their regular treatment. The main questions of this study are: - Does the device function as intended? - Are there any other safety risks that have not been identified? - Does it lower the symptoms of the patients as intended? Doctors and patients will answer questions regarding the improvement of the patients´ symptoms and if there were any problems with the catheter.
The drainova® ArgentiC Catheter initially received the CE mark in 2019 under the Medical Device Directive 93/42/EEC, thus being considered a legacy device under the Medical Device Regulation (EU) 2017/745 (MDR). In order to fulfill the requirements of the MDR, this PMCF study is planned to be conducted to obtain clinical data on the device confirming its safety, performance and clinical benefit in clinical routine according to the instructions for use (IFU). This PMCF study is performed as a purely observational activity within the current standards of care and without additional invasive or burdensome procedures. The drainova® ArgentiC catheter is a catheter indicated for the treatment of patients with pleural effusions and ascites, both in the malignant and non-malignant manifestations. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04159831 -
A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions
|
Phase 2 | |
| Recruiting |
NCT02891642 -
Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
|
||
| Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
| Completed |
NCT02045641 -
Pleural and Pericardial Effusion Following Open Heart Surgery
|
N/A | |
| Completed |
NCT01948076 -
Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination
|
N/A | |
| Completed |
NCT01416519 -
Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation
|
N/A | |
| Completed |
NCT01560078 -
Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion
|
N/A | |
| Completed |
NCT04891705 -
Point of Care Ultrasound Lung Artificial Intelligence (AI) Validation Data Collection Study
|
||
| Recruiting |
NCT05759117 -
Prospective Evaluation of Patients With Pleural Effusion
|
||
| Recruiting |
NCT05910112 -
Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
|
||
| Completed |
NCT03896672 -
Clinical Implementation of the Use of Positive Pressure in Chest Drainage
|
N/A | |
| Active, not recruiting |
NCT06075836 -
AI Assisted Detection of Chest X-Rays
|
||
| Recruiting |
NCT03728491 -
Education and Training Competences in Thoracic Ultrasound
|
N/A | |
| Not yet recruiting |
NCT03260088 -
Evaluation Of Pleural Effusion At Assiut University Hospital
|
N/A | |
| Completed |
NCT03535883 -
The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants
|
||
| Completed |
NCT03296280 -
Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
|
||
| Completed |
NCT03661801 -
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
|
||
| Completed |
NCT01778270 -
Not Invasive Monitoring of Pleural Drainage
|
N/A | |
| Terminated |
NCT00402896 -
Malignant Pleural Effusion With ZD6474
|
Phase 2 | |
| Recruiting |
NCT00103766 -
Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion
|
N/A |